Tatva Chintan Pharma IPO subscription to start from 16 July 2021, Friday. The retail portion of this IPO is 35%, QIB is 50% and HNI is 15% quota. The market is on a roll and the primary market is booming with superb listing. The premium is on a higher side and we will witness a good subscription numbers in the IPO as the IPO is small with just ₹450 crores. The Tatva Chintan Pharma price band is fixed at ₹1073 to ₹1083 Per Share with face value of ₹10 Per Equity Share. The minimum bid is for 13 Shares (₹14,079) and maximum bid is 182 shares (197,106). Tatva Chintan Pharma IPO to raise ₹450 Crores via initial public offer. Please check the Tatva Chintan Pharma IPO details over here.
IPOWatch View
We recommend investors to apply this IPO with short term and long term gain. The IPO Subscription is not started yet!
Brokerage Firm IPO Review & Recommendations
- Axis Capital: Neutral
- Capital Market: May Apply
- Investmentz: Apply
- KR Choksey Securities: Apply
- Motilal Oswal: Apply
- Reliance Securities: Apply
- Sharekhan: Neutral
- Ventura Securities: Apply
Tatva Chintan Pharma IPO Subscription Status (Final Data)
(Over Subscribed)
The Tatva Chintan IPO subscribed 180.35x times till 05:00 PM as on Jul 20, 2021. The public issue subscribed 35.34x in retail, 185.23x in the QIB and 512.22x in the NII.
| Category | Day 1 | Day 2 | Day 3 |
| QIB | 0.50x | 1.97x | 185.23x |
| NII | 1.13x | 12.21x | 512.22x |
| RII | 8.23x | 23.74x | 35.34x |
| Total | 4.50x | 15.05x | 180.35x |
Tatva Chintan Pharma IPO Date & Price Band
| IPO Open: | 16 July 2021 |
| IPO Close: | 20 July 2021 |
| IPO Size: | Approx ₹450 Crores |
| Fresh Issue: | Approx ₹225 Crores |
| Offer for Sale: | Approx ₹225 Crores |
| Face Value: | ₹10 Per Equity Share |
| Price Band: | ₹1073 to ₹1083 Per Share |
| Listing on: | BSE & NSE |
| Retail Portion: | 35% |
| Equity: | – Shares |
| Discount: | N/A |
Tatva Chintan Pharma IPO Market Lot
| Minimum Lot Size: | Minimum 13 Shares |
| Minimum Amount: | ₹14,079 |
| Maximum Lot Size: | Maximum 182 Shares |
| Maximum Amount: | ₹197,106 |
Tatva Chintan Pharma IPO Allotment & Listing
| Basis of Allotment: | 26 July 2021 |
| Refunds: | 27 July 2021 |
| Credit to Demat Account: | 28 July 2021 |
| Listing Date: | 29 July 2021 |
Tatva Chintan Pharma IPO Subscription FAQs:
When Tatva Chintan Pharma IPO Subscription will start?
The IPO subscription starts on 16 July 2021 for QIB, NII, and Retail Investors.
How much Tatva Chintan Pharma IPO subscribed?
The IPO subscribed 180.35x times on day 3.
What is Tatva Chintan Pharma IPO Retail subscription status?
The RII subscription is 35.34x on day 3.
How to subscribe Tatva Chintan Pharma IPO?
You can go with ASBA and Non ASBA option for subscription. Go to your bank account and apply IPO online via ASBA or download form online or get the physical form and submit the filled form to your broker or bank.
How do i check live Tatva Chintan Pharma IPO Subscription Numbers?
One can visit our portal for live subscription numbers which we are updating hourly basis or check the numbers on NSE and BSE website.
